BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2582443)

  • 1. Expression and precursor processing of neuropeptide Y in human and murine neuroblastoma and pheochromocytoma cell lines.
    O'Hare MM; Schwartz TW
    Cancer Res; 1989 Dec; 49(24 Pt 1):7015-9. PubMed ID: 2582443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors.
    O'Hare MM; Schwartz TW
    Cancer Res; 1989 Dec; 49(24 Pt 1):7010-4. PubMed ID: 2582442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours.
    Bjellerup P; Theodorsson E; Jörnvall H; Kogner P
    Br J Cancer; 2000 Jul; 83(2):171-6. PubMed ID: 10901366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
    Higuchi H; Iwasa A; Yoshida H; Miki N
    Mol Pharmacol; 1990 Nov; 38(5):614-23. PubMed ID: 2233698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHO cells synthesize amidated neuropeptide Y from a C-peptide deleted form of the precursor.
    Johansen TE; O'Hare MM; Wulff BS; Schwartz TW
    Endocrinology; 1991 Jul; 129(1):553-5. PubMed ID: 2055204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial processing of the neuropeptide Y precursor in transfected CHO cells.
    Wulff BS; O'Hare MM; Boel E; Theill LE; Schwartz TW
    FEBS Lett; 1990 Feb; 261(1):101-5. PubMed ID: 2307227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of neuropeptide Y in porcine tissues and generation of N-terminal fragments in neuroblastoma cell lines.
    O'Hare MM; Schwartz TW
    Peptides; 1996; 17(1):147-53. PubMed ID: 8822524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of neuropeptide Y and its precursor in plasma and follicular fluid.
    Jørgensen JC; O'Hare MM; Andersen CY
    Endocrinology; 1990 Oct; 127(4):1682-8. PubMed ID: 2205476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
    Jalava A; Mai S
    Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of two homologous precursors, pro-neuropeptide Y and pro-pancreatic polypeptide, in transfected cell lines expressing different precursor convertases.
    Wulff BS; Johansen TE; Dalbøge H; O'Hare MM; Schwartz TW
    J Biol Chem; 1993 Jun; 268(18):13327-35. PubMed ID: 8514771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
    Körner M; Waser B; Reubi JC
    Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of neuropeptide Y from pheochromocytomas.
    Takahashi K; Mouri T; Sone M; Murakami O; Itoi K; Ohneda M; Yoshinaga K
    Endocrinol Jpn; 1990 Feb; 37(1):53-60. PubMed ID: 2384052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma.
    Allen JM; Yeats JC; Causon R; Brown MJ; Bloom SR
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1199-204. PubMed ID: 3571423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic regulation of neuropeptide Y synthesis and release in human neuroblastoma cells.
    Dozio E; Ruscica M; Feltrin D; Motta M; Magni P
    Peptides; 2008 Mar; 29(3):491-5. PubMed ID: 18155321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of neuropeptide Y immunoreactivity in patients with pheochromocytoma: influence on the diagnostic power of measuring plasma NPY using antisera with different specificities.
    Tabarin A; Cassiède P; Minot AP; Cuber JC; Roger P; Ducassou D
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):243-50. PubMed ID: 8480474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of the prohormones proenkephalin, pro-neuropeptide Y, proopiomelanocortin, and beta-protachykinin for in vitro prohormone processing.
    Hook VY; Moran K; Kannan R; Kohn A; Lively MO; Azaryan A; Schiller M; Miller K
    Protein Expr Purif; 1997 Jun; 10(1):80-8. PubMed ID: 9179294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial targeting signal in human neuropeptide Y gene.
    Kaipio K; Kallio J; Pesonen U
    Biochem Biophys Res Commun; 2005 Nov; 337(2):633-40. PubMed ID: 16199004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines.
    Sheikh SP; O'Hare MM; Tortora O; Schwartz TW
    J Biol Chem; 1989 Apr; 264(12):6648-54. PubMed ID: 2708330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of prosalusin in human neuroblastoma cells.
    Nakayama C; Shichiri M; Sato K; Hirata Y
    Peptides; 2009 Jul; 30(7):1362-7. PubMed ID: 19540434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.